How are immunotherapies re-shaping the treatment of lymphoma
Catherine Bollard et al.
Upcoming trials for DLBCL: R-CHOP with acalabrutinib and obinutuzumab with checkpoint inhibitor
Can ibrutinib be used as a first-line treatment in CLL?
Immunotherapy highlights in multiple myeloma at ASH 2016
Niels van de Donk
What are the alternatives to R-CHOP in diffuse large B-cell lymphoma?